Contact information
Milensu Shanyinde
MSc, PhD
Lead Statistician
I joined the Department in 2014 after previously working at the Centre for Statistics in Medicine, collaborating on a variety of clinical studies (predominately randomised controlled trials) and supported.
I have over ten years’ experience in providing statistical support and working collaboratively in clinical trials from design stage to dissemination of results. My experience spans different data types (RCTs and Observational) and disease areas including cancer studies, cardiovascular, mental health, vaccine related, respiratory illness and infectious disease.
In 2015 I went to pursue in PhD in Epidemiology at University College London. Primarily analysing data using of an observational cohort study of HIV patients with or without hepatitis C. I then returned to the department in 2018.
I am a currently a trial statistician on numerous studies in addition I was one of the trial statisticians of an adaptive decentralised clinical trial to evaluate treatment for COVID-19 in the community (PRINCIPLE).
I have published over 20 articles in peer-reviewed journals. I have peer reviewed more 100 publications.
I am one of the module co-ordinators for the Statistics in Clinical course. I am an adviser for the NIHR Research Support Service (NIHR-RSS). I am also a member of data and safety monitoring committee, and the trial steering committee of national trials.
My research interests include, randomisation methods, representation of minorities in trials and missing data in clinical trials.
Recent publications
-
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Journal article
Hobbs FR. et al, (2024), Journal of Infection, 89
-
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Journal article
Hayward G. et al, (2024), Journal of Infection, 88
-
Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management The POP-HT Randomized Clinical Trial
Journal article
Kitt J. et al, (2023), JAMA, 330, 1991 - 1999
-
Clinical diagnosis of SARS-CoV-2 infection: An observational study of respiratory tract infection in primary care in the early phase of the pandemic
Journal article
van der Velden AW. et al, (2023), European Journal of General Practice, 29
-
Efficacy and safety of a modified vaccinia ankara-np+m1 vaccine combined with qiv in people aged 65 and older: A randomised controlled clinical trial (invictus)
Journal article
Butler C. et al, (2021), Vaccines, 9
-
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?
Journal article
Shanyinde M. et al, (2019), BMC Public Health, 19
-
Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study
Journal article
Leone S. et al, (2018), European Journal of Clinical Microbiology and Infectious Diseases, 37, 871 - 881
-
HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients
Journal article
Saracino A. et al, (2018), PLoS ONE, 13
-
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort
Journal article
Monforte ADA. et al, (2017), PLoS ONE, 12
-
Mobile Phone Text Messages to Support Treatment Adherence in Adults with High Blood Pressure (SMS-Text Adherence Support [StAR]): A Single-Blind, Randomized Trial
Journal article
Bobrow K. et al, (2016), Circulation, 133, 592 - 600